Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07338695

The Effect of Photobiomodulation on Microvascular Blood Flow: The Role of Wavelength and Skin Temperature

Evaluation of Hemodynamic Changes in Peripheral Microcirculation in Response to Photobiomodulation Using Non-Invasive Optical and Thermal Technologies

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Afeka, The Tel-Aviv Academic College of Engineering · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to assess peripheral microcirculatory hemodynamic responses to photobiomodulation in participants with normal circulation and with functional peripheral vasoconstriction, using noninvasive thermography, photoplethysmography, and laser Doppler flowmetry.

Detailed description

This is a within-subject experimental study in which each participant completes two study sessions. Microvascular and systemic variables are continuously monitored in response to photobiomodulation delivered at either a blue or near-infrared wavelength, with each wavelength applied in a separate session. Each session includes a baseline period with controlled breathing, followed by photobiomodulation and a 20-minute post-intervention follow-up period. Peripheral microcirculatory responses are assessed using noninvasive thermography, photoplethysmography, and laser Doppler flowmetry.

Conditions

Interventions

TypeNameDescription
DEVICEPhotobiomodulation - Blue WavelengthPhotobiomodulation delivered at a blue wavelength (400-500 nm) to the hands during a single study session as part of a randomized crossover design.
DEVICEPhotobiomodulation - Near InfraredPhotobiomodulation delivered at a near-infrared wavelength (780-1100 nm) to the hands during a single study session as part of a randomized crossover design.

Timeline

Start date
2026-01-01
Primary completion
2027-12-01
Completion
2028-12-01
First posted
2026-01-14
Last updated
2026-01-14

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT07338695. Inclusion in this directory is not an endorsement.